The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Export 11032 results:
[ Author(Desc)] Title Type Year
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Founti, P., Haidich A-B., Chatzikyriakidou A., Salonikiou A., Anastasopoulos E., Pappas T., et al. (2015).  Ethnicity-Based Differences in the Association of LOXL1 Polymorphisms with Pseudoexfoliation/Pseudoexfoliative Glaucoma: A Meta-Analysis.. Ann Hum Genet. 79(6), 431-50.
Founti, P., Topouzis F., van Koolwijk L., Traverso C. E., Pfeiffer N., & Viswanathan A. C. (2009).  Biobanks and the importance of detailed phenotyping: a case study--the European Glaucoma Society GlaucoGENE project.. Br J Ophthalmol. 93(5), 577-81.
Fountoulakis, K. N., Gonda X., Vieta E., & Schmidt F. (2009).  Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.. Ann Gen Psychiatry. 8, 27.
Fountoulakis, K. N., Gonda X., Andreoulakis E., Fokas K., & Iacovides A. (2013).  No differences between drug naive and drug experienced unipolar depressed patients in terms of neurobiological testing: a cross sectional study.. J Psychiatr Res. 47(12), 1984-90.
Fountoulakis, K. N., Moeller H-J., Kasper S., Tamminga C., Yamawaki S., Kahn R., et al. (2020).  The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia.. CNS Spectr. 1-25.
Fountoulakis, K. N., & Möller H-J. (2011).  Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.. Int J Neuropsychopharmacol. 14(3), 405-12.
Fountoulakis, K. N., & Möller H-J. (2012).  Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue.. J Psychopharmacol. 26(5), 744-50.
Fountoulakis, K. N. (2020).  Brain Volume Changes Under Treatment With Antipsychotics.. JAMA Psychiatry. 77(8), 876-877.
Fountoulakis, K. N., Karavelas V., Moysidou S., Mavridis D., Pastiadis K., Petalidou N., et al. (2019).  Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study.. Pharmacopsychiatry. 52(4), 193-202.
Fountoulakis, K. N., Panagiotidis P., Kimiskidis V., Nimatoudis I., & Gonda X. (2019).  Neurological soft signs in familial and sporadic schizophrenia.. Psychiatry Res. 272, 222-229.
Fountoulakis, K. N., Balaris D., Nikolaou V., & Νimatoudis J. (2016).  [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].. Psychiatriki. 27(4), 253-263.
Fountoulakis, K. N. (2017).  DSM-III-R change in definition might have affected placebo response to antidepressants.. Lancet Psychiatry. 4(1), 21-22.
Fountoulakis, K. N., Panagiotidis P., Gonda X., Kimiskidis V., & Nimatoudis I. (2019).  Corrigendum to "Neurological soft signs significantly differentiate schizophrenia patients from healthy controls"; [Acta Neuropsychiatrica 2018;30(2):97-105].. Acta Neuropsychiatr. 31(1), 61.
Fountoulakis, K. N., Siamouli M., Magiria M., Pantoula E., Moutou K., Kemeridou M., et al. (2014).  Standardization of the TEMPS-A in the Greek general population.. J Affect Disord. 158, 19-29.
Fountoulakis, K. N., Yatham L. N., Grunze H., Vieta E., Young A. H., Blier P., et al. (2020).  The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.. Int J Neuropsychopharmacol. 23(4), 230-256.
Fountoulakis, K. N. (2015).  Treatment guidelines for mental disorders: reality or illusion?. Psychiatriki. 26(2), 89-92.
Fountoulakis, K. N., Panagiotidis P., Theofilidis A. T., & Nimatoudis I. (2020).  One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study.. Clin Psychopharmacol Neurosci. 18(3), 434-444.
Fountoulakis, K. N., Pavlidis I., & Tsolaki M. (2011).  Life events and dementia: what is the nature of their relationship?. Psychiatry Res. 190(1), 156-8.
Fountoulakis, K. N. (2012).  Past, present and future in the treatment of major psychotic disorders.. Curr Pharm Des. 18(12), 1557.
Fountoulakis, K. N., Savopoulos C., Zannis P., Apostolopoulou M., Fountoukidis I., Kakaletsis N., et al. (2016).  Climate change but not unemployment explains the changing suicidality in Thessaloniki Greece (2000-2012).. J Affect Disord. 193, 331-8.
Fountoulakis, K. N., & Souliotis K. (2019).  The right to choose treatment-without-treatment: respecting civil rights or an unprecedented manifestation of 'reverse stigma'?. Acta Neuropsychiatr. 31(1), 56-58.
Fountoulakis, K. N., Koupidis S. A., Grammatikopoulos I. A., & Theodorakis P. N. (2013).  First reliable data suggest a possible increase in suicides in Greece.. BMJ. 347, f4900.
Fountoulakis, K. N., Vieta E., & Schmidt F. (2011).  Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis.. J Affect Disord. 133(3), 361-70.
Fountoulakis, K. N. (2010).  Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'.. Ann Gen Psychiatry. 9, 3.
Fountoulakis, K. N., Yatham L., Grunze H., Vieta E., Young A., Blier P., et al. (2017).  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.. Int J Neuropsychopharmacol. 20(2), 121-179.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.